Leiomyosarcoma Clinical Trials in Nashville, Tennessee

4 studies are recruiting for leiomyosarcoma in Nashville, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

    This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival. After…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
    Locations
    175 in total
    Run by
    European Organisation for Research and Treatment of Cancer - EORTC

    See if you can join NCT04031677 on ClinicalTrials.gov

  2. Localized Leiomyosarcoma Biomarker Protocol

    * Leiomyosarcoma (LMS) is one of the more common soft tissue sarcomas (STS). * Patients presenting with large, high-grade, localized LMS are at significant risk of developing metastasis following curative surgery. * Clinical trials of neoadjuvant or adjuvant anthracycline and ifosfamide have sugges…

    Stage
    Not phased
    Ages
    Any age
    Site
    Vanderbilt University Medical Center, Nashville, Tennessee
    Locations
    3 in total
    Run by
    University of Michigan Rogel Cancer Center

    See if you can join NCT04925089 on ClinicalTrials.gov

  3. Metastatic Leiomyosarcoma Biomarker Protocol

    Leiomyosarcoma (LMS) is one of the most prevalent soft tissue sarcomas (STS) and can occur in various sites including soft tissue, uterus and retroperitoneal large vessels. Metastatic disease occurs in approximately 50% of patients diagnosed with leiomyosarcoma and prognosis is poor in setting of m…

    Stage
    Not phased
    Ages
    Any age
    Site
    Vanderbilt University Medical Center, Nashville, Tennessee
    Locations
    11 in total
    Run by
    University of Michigan Rogel Cancer Center

    See if you can join NCT05653388 on ClinicalTrials.gov

  4. Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

    THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study evaluates the safety and efficacy of AL3818 (anlotinib) hydrochloride in the treatment of metastatic or advanced alveolar soft pa…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Vanderbilt University, Nashville, Tennessee
    Locations
    24 in total
    Run by
    Advenchen Laboratories, LLC

    See if you can join NCT03016819 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.